Last reviewed · How we verify

NCT01761760

Videogame-based Incentives for Smoking Cessation

Terminated NA Last updated 26 April 2019
What this trial tests

NA trial testing Videogame-based smoking cessation intervention in Smoking Cessation in 24 participants. Terminated before completion.

Timeline
8 May 2017
Primary endpoint
30 July 2018
30 July 2018

Quick facts

Lead sponsorRowan University
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposehealth services research
Enrollment24
Start date8 May 2017
Primary completion30 July 2018
Estimated completion30 July 2018
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Rowan University

Who can join

18 and older, any sex, with Smoking Cessation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Investigators will be evaluating an online video-game-based smoking cessation intervention that will overcome barriers to treatment such as cost and sustainability. This videogame will be the first of its kind, based on an evidence-based intervention shown to promote smoking abstinence. The findings from this research will be of great public health significance because of the unprecedented reach and relatively low cost, as well as the potential for similar interventions to be developed for other health problems, such as alcohol or drug abuse and medication adherence for chronic illnesses

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Smoking Cessation

Currently open trials in the same condition.

Other Rowan University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01761760.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing